Dong-A and Green Cross to see sustained growth next year
Published: 2011-12-15 07:00:00
Updated: 2011-12-15 07:00:00
Despite the government’s pressure to cut drug prices and fierce competition, Dong-A Pharmaceutical and Green Cross Corp. will see their revenue and operating profit surge next year, according to a report released by IBK Investment Securities.
The report indicated that the sales of Dong-A will ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
